The Patent Finder

Essential Therapeutics, Inc.

Also on record
Records under this name other than patents Essential Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Essential Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 6,399,629Efflux pump inhibitors
Formerly held
Term ended
Term ended Jul 1, 2018 · From the USPTO record
Term endedTerm ended Jul 1, 2018From the USPTO record
US 6,436,980Peptidomimetic efflux pump inhibitors
Formerly held
Term ended
Term ended Jun 3, 2018 · From the USPTO record
Term endedTerm ended Jun 3, 2018From the USPTO record
US 7,056,917Drug efflux pump inhibitor
Formerly held
Lapsed on the fee record
Ended Jun 6, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2014From the USPTO record
US 6,245,746Efflux pump inhibitors
Formerly held
Lapsed on the fee record
Ended Jun 12, 2013 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2013From the USPTO record
US 6,204,279Peptidomimetic efflux pump inhibitors
Formerly held
Lapsed on the fee record
Ended Mar 20, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 20, 2013From the USPTO record
US 6,114,310Efflux pump inhibitors
Formerly held
Lapsed on the fee record
Ended Sep 5, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 5, 2012From the USPTO record
US 6,750,038Rapid antibiotic susceptibility test
Formerly held
Lapsed on the fee record
Ended Jun 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 15, 2012From the USPTO record
US 7,345,048Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
Formerly held
Lapsed on the fee record
Ended Mar 18, 2012 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2012From the USPTO record
US 6,630,303Methods of screening for compounds active on Staphylococcus aureus target genes
Lapsed on the fee record
Ended Oct 7, 2011 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2011From the USPTO record
US 6,514,746Staphylococcus aureus histidine protein kinase essential genes
Lapsed on the fee record
Ended Feb 4, 2011 · From the USPTO record
Lapsed on the fee recordEnded Feb 4, 2011From the USPTO record
10 of 38 patents shown.
Pro members see all 38.
Pro members: see all 38 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited